NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Nova Eye Medical Limited (AU: EYE)
EYE Technical Analysis
As on 2nd Apr 2025 EYE STOCK Price closed @ 0.10 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.22 & Strong Sell for SHORT-TERM with Stoploss of 0.17 we also expect STOCK to react on Following IMPORTANT LEVELS. |
EYESTOCK Price
Open | 0.10 | Change | Price | % |
High | 0.10 | 1 Day | 0.00 | 0.00 |
Low | 0.10 | 1 Week | 0.00 | 0.00 |
Close | 0.10 | 1 Month | -0.02 | -16.67 |
Volume | 101194 | 1 Year | -0.10 | -50.00 |
52 Week High 0.30 | 52 Week Low 0.09 |
AU Australia Most Active Stocks
WHK | 0.02 | -33.33% |
KNB | 0.05 | 25.00% |
CRS | 0.05 | -16.67% |
SYA | 0.02 | 0.00% |
STM | 0.01 | 0.00% |
PLS | 1.54 | -3.14% |
BTH | 0.22 | 0.00% |
RMX | 0.01 | 0.00% |
TLS | 4.32 | 1.17% |
IMU | 0.03 | 0.00% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
EYE Daily Charts |
EYE Intraday Charts |
Whats New @ Bazaartrend |
EYE Free Analysis |
|
EYE Important Levels Intraday
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
RESISTANCE | 0.10 |
EYE Forecast April 2025
4th UP Forecast | 0.29 |
3rd UP Forecast | 0.23 |
2nd UP Forecast | 0.19 |
1st UP Forecast | 0.15 |
1st DOWN Forecast | 0.05 |
2nd DOWN Forecast | 0.01 |
3rd DOWN Forecast | -0.03 |
4th DOWN Forecast | -0.09 |
EYE Weekly Forecast
4th UP Forecast | 0.18 |
3rd UP Forecast | 0.15 |
2nd UP Forecast | 0.14 |
1st UP Forecast | 0.12 |
1st DOWN Forecast | 0.08 |
2nd DOWN Forecast | 0.06 |
3rd DOWN Forecast | 0.05 |
4th DOWN Forecast | 0.02 |
EYE Forecast2025
4th UP Forecast | 0.54 |
3rd UP Forecast | 0.4 |
2nd UP Forecast | 0.31 |
1st UP Forecast | 0.23 |
1st DOWN Forecast | -0.03 |
2nd DOWN Forecast | -0.11 |
3rd DOWN Forecast | -0.2 |
4th DOWN Forecast | -0.34 |
Nova Eye Medical Limited ( AU Australia Symbol : EYE )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
EYE Business Profile
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services medical devices to treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate glaucoma openangle glaucoma; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, Asia, South America, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia. Address: 107 Rundle Street, Kent Town, SA, Australia, 5067
� 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service